Carbimazole-induced leukocytoclastic vasculitis: A case report;Carbimazole et vascularite leucocytoclasique: A propos d'un cas

Revue de Medecine Interne

Volumn 20, Issue 4, 1999, Pages 350-352

  Yazbeck, R ^a   Francoual, J ^a   Benoit, P ^a   Tauveron, I ^b   Tchen, C ^a   Thieblot, P ^a  

^a HÔPITAL DU BOCAGE   (France)

^b UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

Author keywords

Carbimazole; Vasculitis

Indexed keywords

CARBIMAZOLE;

AGED; ARTICLE; CASE REPORT; FEMALE; HUMAN; IMMUNE COMPLEX DISEASE; LEUKOCYTOCLASTIC VASCULITIS; MYOSITIS; NEPHRITIS; STEROID THERAPY;

EID: 0032718816     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(99)83076-8     Document Type: Article

References (9)

1. Ducornet B, Duprey J. Effet s secondaires des antithyroïdiens de synthèse. Ann Méd Interne. 139:1988;410-431.
2. Burell CD, Fraser R, Doniach D. The low toxicity of carbimazole. A survey of 1,046 patients. Br Med J. 1:1956;1453-1456.
3. Pasquier E, Genereau T, Baudrimont M, Cabane J, Biour M, Imbert JC. Biopsy-proven myositis with microvasculitis in association with carbimazole. Lancet. 338:1991;1082-1083.
4. D'Cruz D, Chesser AMS, Lightowler C, Comer M, Hurst MJ, Baker LRI, et al. Antineutrophil cytoplasmic antibody positive crescentic glomerulonephritis associated with antithyroid drug treatment. Br J Rheum. 34:1995;1090-1091.
5. Cooper DS. Antithyroid drugs. N Engl J Med. 311:1984;1353-1362.
6. Bartalena L, Baugazzi F, Martino E. Adverse effects of thyroid hormone preparations and antithyroid drugs. Drug Safety. 15:1996;53-63.
7. Frances C, Boisnic S, Bletry O. Classification et répertoire des angéites nécrosantes. Rev Prat. 39:1989;2029-2036. (Paris).
8. Calabrese LH, Duna GF. Drug-induced vasculitis. Curr Opin Rheumatol. 8:1996;34-40.
9. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med. 331:1994;1272-1284.